Sangamo Therapeutics
SGMO
SGMO
111 hedge funds and large institutions have $42.1M invested in Sangamo Therapeutics in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
10.66% less ownership
Funds ownership: 31.41% → 20.75% (-11%)
16% less call options, than puts
Call options by funds: $989K | Put options by funds: $1.18M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
111
Holding in Top 10
–
Calls
$989K
Puts
$1.18M
Top Buyers
| 1 | +$2.25M | |
| 2 | +$1.51M | |
| 3 | +$1.48M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.11M |
| 5 |
Two Sigma Investments
New York
|
+$1.08M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$4.48M | |
| 3 | -$338K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$222K |
| 5 |
BlackRock
New York
|
-$170K |
